20/01/23 -"Previous indication of 3-5% portfolio correction in 4Q22 still realistic – Limited disposals in 4Q but target of 5,000 units are still valid in our view"
20/01/23 -"Previous indication of 3-5% portfolio correction in 4Q22 still realistic – Limited disposals in 4Q but target of 5,000 units are still valid in our view"
AlphaValue does not have nor seek any business with companies covered in AlphaValue Research paid by subscription. As a result, investors can be confident that there is no conflict of interest that could affect the objectivity of AlphaValue Research.
| Corporate broking | NO |
| Trading in corporate shares | NO |
| Analyst ownership | NO |
| Advising of corporate (strategy, marketing, debt, etc) | NO |
| Research paid for by corporate | NO |
| Provision of corporate access paid for by corporate | NO |
| Link between and a banking entity | NO |
| Brokerage activity at AlphaValue | NO |